Ventas (VTR) announces $1.0 billion life science investment.

Ventas, Inc. (VTR) announced today that the Ventas Life Science and Healthcare Real Estate Fund, L.P. has acquired a $1 billion portfolio of life science properties in the South San Francisco submarket.  The Fund is a perpetual life vehicle managed by Ventas with assets under management of $1.8 billion.  The acquired properties consist of three buildings totaling 800,000 sf and are 96% leased with a remaining average lease term of over six years.

Ventas is a large-cap health care REIT with a diversified portfolio of 1,204 properties located in the United States, Canada, and the United Kingdom.  VTR is a member of the S&P 500 and has a total market capitalization of approximately $27 billion.